Nitric oxide and multiple sclerosis

Current Neurology and Neuroscience Reports

Volumn 5, Issue 3, 2005, Pages 232-238

  Encinas, Juan Manuel ^b   Manganas, Louis ^b   Enikolopov, Grigori ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FREE RADICAL; GLUTAMIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

BIOCHEMISTRY; CELL ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG TARGETING; ENZYME ACTIVITY; GENETIC PREDISPOSITION; HUMAN; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL LESION; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL TRANSPLANTATION;

EID: 21044435821     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-005-0051-y     Document Type: Review

References (61)

1. Smith KJ, Lassmann H: The role of nitric oxide in multiple sclerosis. Lancet Neurol 2002, 1:232-241.
2. Parkinson JF, Mitrovic B, Merrill JE: The role of nitric oxide in multiple sclerosis. J Mol Med 1997, 75:174-186.
3. Smith KJ, Kapoor R, Felts PA: Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 1999, 9:69-92.
4. Willenborg DO, Staykova MA, Cowden WB: Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review. J Neuroimmunol 1999, 100:21-35.
5. Bredt DS: Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 1999, 31:577-596.
6. Ignarro LJ: Nitric Oxide: Biology and Pathobiology, edn 1. San Diego: Academic Press; 2000.
7. Nathan C: Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Invest 2003, 111:769-778.
8. Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: structure, function and inhibition. Biochem J 2001, 357:593-615.
9. Nathan C: Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997, 100:2417-2423.
10. Ridnour LA, Thomas DD, Mancardi D, et al.: The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol Chem 2004, 385:1-10.
11. Fang FC: Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rep Microbiol 2004, 2:820-832.
12. Hess DT, Matsumoto A, Kim SO, et al.: Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2005, 6:150-166.
13. Chung KK, Thomas B, Li X, et al.: S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 2004, 304:1328-1331.
14. Yao D, Gu Z, Nakamura T, et al.: Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A 2004, 101:10810-10814.
15. Bryan NS, Rassaf T, Maloney RE, et al.: Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc Natl Acad Sci U S A 2004, 101:4308-4313.
16. Janero DR, Bryan NS, Saijo F, et al.: Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo. Proc Natl Acad Sci U S A 2004, 101:16958-16963.
17. Baker PR, Schopfer FJ, Sweeney S, Freeman BA: Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. Proc Natl Acad Sci U S A 2004, 101:11577-11582.
18. Liu X, Miller MJ, Joshi MS, et al.: Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci U S A 1998, 95:2175-2179.
19. Schopfer FJ, Lin Y, Baker PR, et al.: Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor (gamma) ligand. Proc Natl Acad Sci U S A 2005, 102:2340-2345.
20. Lundberg JO, Weitzberg E, Cole JA, Benjamin N: Nitrate, bacteria and human health. Nat Rev Microbiol 2004, 2:593-602.
21. Blanco Y, Yague J, Graus F, Saiz A: No association of inducible nitric oxide synthase gene (NOS2A) to multiple sclerosis. J Neurol 2003, 250:598-600.
22. Tajouri L, Martin V, Ovcaric M, et al.: Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population. Brain Res Bull 2004, 64:9-13.
23. Tajouri L, Ferreira L, Ovcaric M, et al.: Investigation of a neuronal nitric oxide synthase gene (NOS1) polymorphism in a multiple sclerosis population. J Neurol Sci 2004, 218:25-28.
24. Barcellos LF, Begovich AB, Reynolds RL, et al.: Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann Neurol 2004, 55:793-800.
25. Kanwar JR, Kanwar RK, Krissansen GW: Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 2004, 127:1313-1331.
26. Broholm H, Andersen B, Wanscher B, et al.: Nitric oxide synthase expression and enzymatic activity in multiple sclerosis. Acta Neurol Scand 2004, 109:261-269.
27. Hill KE, Zollinger LV, Watt HE, et al.: Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage. J Neuroimmunol 2004, 151:171-179.
28. Acar G, Idiman F, Idiman E, et al.: Nitric oxide as an activity marker in multiple sclerosis. J Neurol 2003, 250:588-592.
29. Danilov AI, Andersson M, Bavand N, et al.: Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J Neuroimmunol 2003, 136:112-118.
30. Rejdak K, Eikelenboom MJ, Petzold A, et al.: CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology 2004, 63:1439-1445.
31. Garthwaite G, Goodwin DA, Batchelor AM, et al.: Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience 2002, 109:145-155.
32. Hooper DC, Bagasra O, Marini JC, et al.: Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A 1997, 94:2528-2533.
33. Cross AH, Manning PT, Keeling RM, et al.: Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol 1998, 88:45-56.
34. Liu JS, Zhao ML, Brosnan CF, Lee SC: Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 2001, 158:2057-2066.
35. Kahl KG, Schmidt HH, Jung S, et al.: Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response. Neurosci Lett 2004, 358:58-62.
36. Touil T, Deloire-Grassin MS, Vital C, et al.: In vivo damage of CNS myelin and axons induced by peroxynitrite. Neuroreport 2001, 12:3637-3644.
37. Scott GS, Spitsin SV, Kean RB, et al.: Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc Natl Acad Sci U S A 2002, 99:16303-16308.
38. Scott GS, Virag L, Szabo C, Hooper DC: Peroxynitrite-induced oligodendrocyte toxicity is not dependent on poly(ADP-ribose) polymerase activation. Glia 2003, 41:105-116.
39. Takao T, Flint N, Lee L, et al.: 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. J Neurochem 2004, 89:660-673.
40. Bizzozero OA, DeJesus G, Howard TA: Exposure of rat optic nerves to nitric oxide causes protein S-nitrosation and myelin decompaction. Neurochem Res 2004, 29:1675-1685.
41. Calabrese V, Scapagnini G, Ravagna A, et al.: Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J Neurosci Res 2002, 70:580-587.
42. Boullerne AI, Rodriguez JJ, Touil T, et al.: Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neurosci 2002, 22:123-132.
43. Boullerne AI, Petry KG, Meynard M, Geffard M: Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J Neuroimmunol 1995, 60:117-124.
44. McDonald JW, Althomsons SP, Hyrc KL, et al.: Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 1998, 4:291-297.
45. Pitt D, Werner P, Raine CS: Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 2000, 6:67-70.
46. Rosin C, Bates TE, Skaper SD: Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms. J Neurochem 2004, 90:1173-1185.
47. Pitt D, Nagelmeier IE, Wilson HC, Raine CS: Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology 2003, 61:1113-1120.
48. Mander P, Borutaite V, Moncada S, Brown GC: Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death. J Neurosci Res 2005, 79:208-215.
49. Lassmann H: Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci 2003, 206:187-191.
50. Aboul-Enein F, Lassmann H: Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? Acta Neuropathol (Berl) 2005, 109:49-55.
51. Bossy-Wetzel E, Talantova MV, Lee WD, et al.: Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 2004, 41:351-365.
52. Kahl KG, Zielasek J, Uttenthal LO, et al.: Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. J Neurosci Res 2003, 73:198-205.
53. Staykova MA, Paridaen JT, Cowden WB, Willenborg DO: Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis. Am J Pathol 2005, 166:147-157.
54. Okuda Y, Sakoda S, Fujimura H, Yanagihara T: Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase. J Neuroimmunol 1998, 81:201-210.
55. O'Brien NC, Charlton B, Cowden WB, Willenborg DO: Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease. J Immunol 2001, 167:5904-5912.
56. Xu LY, Yang JS, Link H, Xiao BG: SIN-1, a nitric oxide donor, ameliorates experimental allergic encephalomyelitis in Lewis rats in the incipient phase: the importance of the time window. J Immunol 2001, 166:5810-5816.
57. Imitola J, Snyder EY, Khoury SJ: Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis. Physiol Genomics 2003, 14:171-197.
58. Packer MA, Stasiv Y, Benraiss A, et al.: Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci U S A 2003, 100:9566-9571.
59. Park C, Sohn Y, Shin KS, et al.: The chronic inhibition of nitric oxide synthase enhances cell proliferation in the adult rat hippocampus. Neurosci Lett 2003, 339:9-12.
60. Cheng A, Wang S, Cai J, et al.: Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev Biol 2003, 258:319-333.
61. Moreno-Lopez B, Romero-Grimaldi C, Noval JA, et al.: Nitric oxide is a physiological inhibitor of neurogenesis in the adult mouse subventricular zone and olfactory bulb. J Neurosci 2004, 24:85-95.